Lyrinel XL use in children

The licence for Lyrinel XL (oxybutynin prolonged release) has been extended to include use in children over six years. Previously, use in children under 18 years was not recommended.

The recommended starting dose for children over six years is 5mg once daily, increasing by 5mg increments up to a maximum of 15mg once daily. The safety and efficacy of Lyrinel XL has not been established in patients under six years.

Further information: Janssen-Cilag Ltd 01494 567444

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more